Look Who’s Talking



In 2014 we brought together the CEOs of Reynolds American and Lorillard, the director of the U.S. Food and Drug Administration’s Center for Tobacco Products, anti-illicit trade insiders and leading campaigners against child labor.

The 2015 event in Bologna will build on and expand this already diverse range of voices, including:

Government figures; public health officials; members of medical associations; manufacturers of tobacco, e-cigarettes and NCT’s; suppliers to all aspects of the industry; journalists, including mainstream media and bloggers; financial analysts and investors; leaf companies and farmers; tobacco associations; libertarians; think tanks and consultants.

Whatever aspect of tobacco or related topics they represent, all of our speakers for 2015 will base their presentations on sound evidence, in-depth experience and the willingness to engage with other views.

Profiled below are some of our 2015 speakers.

George Adams is an interventional cardiologist at Rex Hospital and clinical associate professor of medicine at the University of North Carolina, Chapel Hill. He completed his internal medicine internship and residency at the University of Texas Southwestern and his general cardiology fellowship, interventional cardiology fellowship and master’s in health sciences at Duke University.  He is currently a clinical associate professor of medicine at the University of North Carolina at Chapel Hill and is the director of cardiovascular and peripheral vascular research at Rex Hospital. Adams is well-published in the field of complex peripheral vascular interventions in critical limb ischemic patients, development of regional systems of care for STEMI, and nuclear cardiology techniques.  He currently leads a robust clinical research program enrolling patients in approximately 50 peripheral, carotid and coronary trials and is involved with device development for the management of coronary and peripheral vascular disease.

Elizabeth “Liz” Allen has more than 35 years of management, operational and policy experience with Her Majesty’s (HM) Revenue and Customs (HMRC) and previously with HM Customs and Excise. Her senior civil service positions included responsibility for the Alcohol and Tobacco Fraud Review, Excise and Inland Customs Compliance Strategy, implementation of the Excise Movement and Control System and responsibility for the administration of environmental taxes. Allen also worked on customs policy and prosecutions. Since retiring from HMRC in March 2009, Allen has chaired or been a team member of four Major Projects Authority “Starting Gate” policy delivery reviews across four U.K. government departments. From September 2010 to June 2011, Allen led a successful EU-funded review of the illicit trade in excisable products in the Southern African Development Community (SADC). She also facilitated workshops on excise tax policy, administration and enforcement for senior revenue and customs officials in the SADC region. She is the author of the first edition of The Illicit Tobacco Trade and How to Tackle It and the Guidebook to the Successful Introduction of a Specific Excise Tax on Alcohol Beverages, both published by ITIC in 2011.

Jeremy Armstrong started his leaf career in 1983 with Dibrell Brothers in India. Following a number of leaf and product roles within Imperial Tobacco and Rothmans, he joined British American Tobacco (BAT), becoming responsible for their Africa leaf purchase, and was based in South Africa. During his career within BAT he has been responsible for the group leaf purchase, running the BAT Global Leaf Pool, and heading the Regional Product Centre in Asia Pacific. Today, he is once again back in the U.K., purchasing the international leaf requirement.

Vivien Azer is a managing director and senior research analyst specializing in the beverage and tobacco sectors. Azer’s coverage of the tobacco sector has earned her a spot on Institutional Investor’s All-America Research Team on several occasions. In 2015, StarMine ranked Azer No. 3 for earnings estimation in tobacco, and in 2014 she ranked No. 1 in tobacco and No. 3 for earnings estimation in beverages. Prior to joining Cowen and Company in 2014, she spent more than nine years at Citi covering consumer staples. Azer holds a B.A. from the College of William & Mary and an MBA from New York University’s Stern School of Business.

Jason Baits-Tomlin is vice president of strategy and new business of the global tobacco supply chain at JT International. He brings with him more than 20 years of experience in the tobacco industry, producing results from one end of the supply chain to the other. His tobacco history has included leadership positions in finance, equities, general management and business development. His leadership philosophy is one where companies will enjoy: long-term success by giving more for less; more consumer satisfaction and value given to communities in their supply chain; eliminating social issues and securing inputs long-term; more use of cutting edge technology to improve productivity and drive revenue; more employee engagement for sustained high performance; and less cost to the planet and product. Operations are run from renewable energy, products produce no waste and are best-cost without compromising quality.

Scott Ballin has spent 40-plus years working on issues related to tobacco and public health. He served as the American Heart Association’s vice president and legislative counsel, as a steering committee member and as chairman of the Coalition on Smoking or Health. Ballin was instrumental in advocating the regulation of tobacco products by the U.S. Food and Drug Administration. He also worked for the Alliance for Health Economic and Agriculture Development, an organization formed to help enact the recommendations in Tobacco at a Crossroads. He continues work on tobacco harm-reduction issues and serves as an adviser to the University of Virginia on tobacco, nicotine and alternative products/harm-reduction dialogues.

Patrick Basham directs the Democracy Institute, an independent London- and Washington, D.C.-based think tank. A best-selling author, he was previously a Cato Institute senior fellow. Prior to Cato, he led the Fraser Institute’s tobacco regulation research. Basham wrote his doctoral dissertation at Cambridge University and taught tobacco regulation at Johns Hopkins University. He is a global consultant on corporate strategy, branding, social media, polling, regulation and advertising. He appears regularly on American, British and Canadian TV and radio.

Clive Bates has had a diverse career in the public, private and not-for-profit sectors. He started out in IT marketing for IBM then switched careers to work in the environment movement, including for Greenpeace. From 1997–2003 he was director of Action on Smoking and Health (U.K.), campaigning to reduce the harms caused by tobacco. In 2003 he joined Prime Minister Blair’s Strategy Unit as a civil servant and worked in senior roles in the public sector in the U.K. and for the United Nations in Sudan. At the start of 2013, he began developing a new venture, Counterfactual, a consulting and advocacy practice focused on a pragmatic approach to sustainable development, energy policy and public health.

Peter Beckett is head of compliance at Nerudia, responsible for helping clients of all shapes and sizes protect and maintain their vapor businesses in newly regulated environments. Before taking up this role, he was head of public policy for ECITA and played a central role in the political negotiations that led to the adoption of new rules for e-cigarettes as part of the revised EU Tobacco Products Directive (TPD). In the wake of TPD, Beckett was instrumental in the foundation of CEN TC 437, which sets standards for the vapor industry. He has extensive experience in government relations, having acted for various clients in highly regulated industries, including finance, technology and the international fur trade.

Karen Blakeley has over 25 years of experience with leadership development working for multinational organisations such as British Airways, PricewaterhouseCoopers and Barclays Bank. Upon joining Winchester Business School in 2009, she set up the Hoare Centre for Responsible Management and has written about responsible leadership for both scholarly and practitioner publications. Blakeley has been interviewed on TV and radio concerning the dynamics leading to bad leadership. She has written a book on leadership blind spots and currently specializes in responsible leadership development and training.

Erik Bloomquist is senior financial analyst of the global tobacco sector at BESI Grupo Novo Banco. He was ranked No. 2 in the most recent European Extel survey and among the top ranked in the most recent Institutional Investor All-Europe surveys. He previously led the global tobacco team at J.P. Morgan, which, during his leadership, was the only individual team to attain top ranks for tobacco in the European, U.S. and Japanese Institutional Investor surveys concurrently. Areas of special research interest include plain packaging, tobacco harm reduction, reduced-risk products and the Japanese tobacco market. Bloomquist holds an MBA from the University of Wisconsin–Madison and an M.A. from the Henry M. Jackson School of International Studies at the University of Washington.

Michel Bracke is the CEO of Nicoccino Holding AB, a position he has held since July 2013. Following initial consulting work for FFT Medical AB, which invented the platform upon which Nicoccino’s product is built, Bracke started Nicoccino AB with the aim of commercializing the product and establishing Nicoccino as a leading player within the growing market for recreational nicotine products. Nicoccino is a discreet and convenient leaf-thin film that contains 1 mg of nicotine and dissolves under a user’s lip. Initial sales started via the e-commerce site in the summer of 2014. Currently Nicoccino is selling in the U.K., Germany, Czech Republic and Poland with further expansion planned in other selected markets. Bracke also serves as member of the board at Karessa Pharma and is owner and CEO of MRM-Advice AB, a consulting and sales distribution company. Bracke earned a Master of Applied Arts from the Hogeschool Sint-Lukas Brussel in Brussels, Belgium, and is an alumnus of the Harvard Business School.

Theodore G. Broome is executive vice president of Universal Leaf Tobacco Company and is responsible for the company’s global sales efforts. Broome has dedicated 38 years to the tobacco industry and has served in various sales and operational roles in Asia, Europe and the United States. Broome and his family relocated from the United Kingdom to Universal’s Richmond, Virginia, headquarters in 2002 as senior vice president and sales director. He currently serves on Universal Leaf Tobacco Company’s board of directors and executive team along with participating as a member of both the compliance and disclosure committees of the company.

Christopher Butler is chief of staff at Americans for Tax Reform (ATR)—one of Washington, D.C.’s most influential free-market, activist organizations—lobbying and organizing in a dozen issue areas at the state, federal and international levels to promote free and open markets and economic liberty. Since 2008 he has managed the group’s considerable election efforts. Butler also has a role in managing other special projects of ATR, including the Center for Worker Freedom, DigitalLiberty.net and the Cost of Government Center. In cooperation with Lorenzo Montanari, Butler manages the Property Rights Alliance, which is well-known for its annual International Property Rights Index and coalition work on behalf of intellectual property rights. Butler has appeared in national media outlets such as Fox News, NPR, Newsday, The Wall Street Journal and The Washington Post. In recent years, he has trained activists in communications, fundraising and political organizing in Serbia, Boznia-Herzegovina, France, New Zealand, Ireland, Belgium, Malaysia and elsewhere in Europe and Asia.

Cynthia Cabrera is executive director of the Smoke-Free Alternatives Trade Association (SFATA), representing over 500 members throughout the vapor supply chain. Previously vice president of compliance and logistics for VMR Products, Cabrera has an extensive background in logistics and supply chain management and has consulted for global solutions and services. She has a Green Belt in Lean Management and has focused on supply chain management in a variety of industries within manufacturing and service sectors. Cabrera has consulted for many well-known companies, including Kellwood Companies, Atlas Metals, Mark Two Manufacturing, Timbar Packaging and Supply, Bertram Yacht (Ferretti), and Stryker Medical. She is a frequent speaker at industry events and conferences and has presented for Oxfam, World Bank and Anacafe. Working in the vapor space since 2011, Cabrera has become an expert on the vapor industry, including trends, product evolution, distribution channels, and regulatory and legislative issues.

Jeannie Cameron is managing director of JCIC International, a U.K.-based strategic advocacy and public affairs consultancy specializing in advocating the views of business in policy development and within regulatory frameworks. Cameron specializes in anti-illicit trade, track and trace, and tobacco harm reduction, having received a distinction for her master’s in law dissertation—Emerging International Public Health Issues – Human Rights, Harm Reduction and the Framework Convention on Tobacco Control (FCTC)—in 2007. Cameron was at BAT between 2001 and 2011 in the roles of international health affairs manager, international regulatory affairs manager and head of international advocacy, primarily responsible for advice to the BAT group on all aspects of the FCTC treaty and its protocol. Cameron is chair of the OECD’s Task Force on Charting Illicit Trade in Environmentally Sensitive Goods and Wildlife and international regulatory law fellow of the Democracy Institute.

Dmitri Churakov is the Wingle Group’s CEO and provides independent consultancy in the issues related to the traditional tobacco smoking alternatives. With more than eight years of consultancy work experience, Churakov is closely involved in new hookah product development and new vapor products. Having moved from Israel to China, he worked for five years in the technology sector, as well as with a number of leading companies specialized in providing services in the sphere of manufacturer and goods search on the Chinese market. He has experience in the consumer industry, oil-producing industry and electronics. In 2009 he set up with his partners a vapor sector consulting company (the Wingle Group). Since the company was founded, some successful projects have been implemented with a number of large corporations both inside China and around the world, and a team of professionals has been selected and formed, resulting in services of a substantially higher level and across a wider spectrum.

Bruce Clark is vice president of regulatory and scientific affairs at Philip Morris International (PMI), where he leads PMI’s global efforts to attain regulatory approval and marketing authorization for reduced-risk products (RRPs). In this role he also has oversight of PMI’s external scientific engagement activities for RRPs within the regulatory, public health and scientific communities. Clark is also involved in defining and setting the R&D strategy for RRP quality assurance activities to ensure that PMI’s RRP efforts anticipate and meet evolving global regulatory requirements. Prior to joining PMI in January 2013, Clark had more than 25 years of clinical and regulatory experience in the pharmaceutical industry, working in both branded and generic industries dealing with development and regulatory challenges for complex therapeutics such as formulations of second entry inhaled corticosteroids, peptides and biosimilars. Most recently, he served as senior vice president of scientific and regulatory affairs at Apotex Inc., with global responsibility for regulatory affairs, pharmacovigilance, project management and R&D quality assurance.

Simon Clark is director of the smokers lobby group Forest (Freedom Organisation for the Right to Enjoy Smoking Tobacco). He previously worked in public relations, political and media research, publishing, journalism and event management. For 16 years Clark has lobbied on behalf of smokers and tolerant nonsmokers. He appears regularly on radio and television in the U.K. and is frequently quoted by both the print and broadcast media. In recent years he has run a number of campaigns in the U.K. including the Hands Off Our Packs campaign against plain packaging of tobacco and the No Thank EU campaign against the EU’s revised Tobacco Products Directive. This year he launched Action on Consumer Choice, which promotes consumer choice in areas such as food, drink and smokeless tobacco.

John Clayton joined British American Tobacco in 2002 as corporate social responsibility manager at the group’s Japan subsidiary. Over his 13 years in the company, Clayton has held a number of roles at the global, regional and market levels, including vice president of corporate and regulatory affairs (CORA) at the group’s Canadian subsidiary, regional CORA manager of the Americas region, and group head of regulation. Prior to joining BAT, Clayton was manager of Japanese government relations for the American Chamber of Commerce in Japan, advocating on behalf of international business and trade interests in Japan. Clayton is fluent in Japanese and has an M.A. in East Asian studies.

Miguel Coleta has been PMI’s director of external labor policies since 2010, mainly focused on developing and implementing PMI’s Agricultural Labor Practices program. He joined PMI in Portugal in 2005 and moved to the operations center in Lausanne, Switzerland, in 2008, having worked on government affairs, regulatory affairs and harm reduction. Coleta holds a Ph.D. in phytochemistry and pharmacognosy. Prior to joining PMI, he served one term as an elected member of the Portuguese parliament and was an assistant professor at the University of Coimbra in Portugal.

Jose Maria Costa is executive vice president of global operations and supply chain for Alliance One. Costa has held several positions during his 23 years in the industry, from financial roles in South America in the 90s (Brazil and Argentina) with Compania de Filipinas and Intabex to finance/managing director in Italy with Dimon from 1997 until 2005. At the time of the merger between Standard Commercial and Dimon, he became regional financial director for Alliance One in Europe (2005–2008), regional director for Europe (2008–2012), and in 2012 he relocated to AOI Head Office in Morrisville, North Carolina, USA, under his current tittle. Born in Spain, he holds a law degree from the University of Barcelona, a master’s degree in international management from the ESADE Business School and a corporate finance degree from the London Business School.

Martin Cullip is a company director who not only uses e-cigarettes himself but has also experienced the benefits of many of his staff quitting or reducing smoking by vaping instead. As such, he is a passionate consumer advocate of tobacco harm reduction and is now a consumer associate for the New Nicotine Alliance. He stood as a general election candidate for the Libertarian Party in the U.K. in 2010 and writes and blogs on lifestyle issues for outlets such as Spiked, The Free Society and others.

James Cutforth is the global sector manager for tobacco at Domino Printing Sciences, a world leader in industrial coding technologies. Cutforth has been with Domino for more than 20 years in various technical and commercial roles in many industry sectors—for the past 10 years exclusively in tobacco. Cutforth is part of the specialist global sector solutions division, and his team has more than 50 years combined experience in coding tobacco packaging. His role involves supporting both manufacturers and OEMs in the tobacco industry and ensuring that existing and future Domino product offerings satisfy customer requirements for pack, carton and master case identification, with a particular focus on item-level serialization, handling and vision.

Warwick Evans is the senior manager for Africa and global agronomy strategy for Imperial Tobacco. He has worked for Imperial since 2010 and is based out of Durban, South Africa. Evans is responsible for all of Imperial’s leaf purchasing activities conducted in Africa, including commercial, compliancy and sustainability requirements. He has also recently been mandated to give strategic direction to Imperial’s global agronomy objectives. Evans has 37 years of experience in the tobacco industry, having farmed in Zimbabwe and, more recently, on the corporate side of the industry with Imperial Tobacco. He brings a practical and realistic mindset to identifying the synergies between sustainable, responsible tobacco production and the commercial imperative not only from a manufacturing perspective but at supplier and farmer levels as well.

Konstantinos Farsalinos is a cardiologist working as a research fellow and research coordinator at the laboratory of molecular biology and immunology in the department of pharmacology at the University of Patras, Greece, and a researcher with the department of cardiology at Onassis Cardiac Surgery Center. His interests include research on smoking, tobacco harm reduction and electronic cigarettes, at both the laboratory and clinical levels. His experience in e-cigarette research includes performing the first-ever studies evaluating the acute effects of e-cigarette use on myocardial and arterial function and the first-ever studies evaluating the effects of e-cigarette aerosol exposure on cultured live cells. He also performed the largest survey (19,441 participants) on characteristics, patterns of use, benefits and side effects of e-cigarette use in dedicated consumers.

Jon Fell is a founding partner of Ash Park, which advises the MontLake Ash Park Global Consumer Staples UCITS Fund, focused on investments in the fast-moving consumer goods industry. Prior to 2013, he was team head of the consumer equity research group at Deutsche Bank in London, where he covered the tobacco and beverages sectors, following earlier spells at Morgan Stanley and Merrill Lynch. Fell is also a director of Article 36, an organization that works to prevent weapons causing unintended, unnecessary or unacceptable harm.

Dorel Fronea, coordinator of the European Funds Ministry internal control department, has a long track record of skillfully planning and managing actions to prevent and combat illicit traffic of goods, training and motivating teams. Prior to being appointed in the aforementioned position, he was the head of the Romanian National Customs Authority, vice president of the National Agency for Fiscal Administration, a high-level adviser on behalf of European Union High Level Policy Advice Mission – UNDP to the customs service of the Republic of Moldova, and secretary-general of the Ministry of Justice. He has been working in public administration for more than 16 years, holding various management positions in the National Customs Authority, with duties and responsibilities regarding the fight against illicit trafficking and counterfeiting, as well as coordinating the task force group for elaborating the National Strategy for Fighting Against Illicit Traffic with Cigarettes.

Susan Gernert has practiced law for 28 years and is currently assistant general counsel for National Tobacco Company LP, where she has primary responsibility for U.S. FDA compliance. She got her start in the tobacco industry with Brown & Williamson and British American Tobacco, where—among other things—she managed the attorney general product litigation in the U.S. and later served as head of legal and regulatory affairs for a 10-country region in Europe. Gernert has held senior legal positions for other multinational companies, including General Electric and Sud-Chemie. Prior to law school, Gernert worked as an R&D chemist in the distilled spirits industry.

Moira Gilchrist is director of scientific engagement at Philip Morris International Research and Development. Gilchrist is responsible for driving the transparent and comprehensive communication of PMI’s reduced-risk product science to stakeholders in the scientific, public health and regulatory communities. She joined PMI R&D in 2006 and has held a variety of roles focused on the development, assessment and commercialization of reduced-risk products. Gilchrist has 15 years of experience in the pharmaceutical industry, working initially in product development roles and subsequently in management consultancy with PricewaterhouseCoopers and IBM Business Consulting Services.

Kirsty Green-Mann is Imperial Tobacco Group’s head of corporate responsibility and vice president of the Eliminating Child Labour in Tobacco Growing (ECLT) Foundation. Based in Bristol, U.K., her remit includes framing the group’s responsibility strategy, stakeholder engagement, community partnerships, sustainability reporting and human rights. Green-Mann joined Imperial in 1998 and has held a variety of roles, moving from manufacturing to corporate affairs and into sustainability. Green-Mann has served as a member of the ECLT Foundation Board since 2011.

Pierre-Marie Guitton is secretary-general of Coresta, the France-based international association dedicated to cooperative scientific research on tobacco and related products. In this role, he supports researchers worldwide in their work, meetings, collaborative studies and document production. Guitton has worked in the tobacco industry since 1989, starting as technical communication manager with SWM, in charge of creating communications materials for scientific and commercial staff. He then moved on as a customer technical support engineer in SWM’s tipping paper activities. His background is in commercial design and communication.

Jack E. Henningfield is one of the world’s leading experts on addiction, and the behavioral, cognitive, and central nervous system (CNS) effects of various drugs and drug formulations. He joined Pinney Associates in September 1996 after 16 years of public service at the Intramural Research Program of the National Institutes of Health’s National Institute on Drug Abuse (NIDA).

Airton L. Hentschke is executive vice president and chief operating officer of Universal Leaf Tobacco Co. Inc. and senior vice president and chief operating officer of Universal Corp. Hentschke has devoted over 24 years to the tobacco industry. He has served in numerous administrative and financial positions, as well as sales and operational roles throughout South America and in the United States. In 2013, Hentschke and his family relocated to Universal’s headquarters in Richmond, Virginia, USA, from Brazil. He currently serves on the Universal Leaf Tobacco Co. board of directors and executive committee, and he is a vital part of the Universal Corp. board.

Bonnie Herzog is a managing director and senior tobacco, beverage and convenience store analyst at Wells Fargo Securities. Prior to joining Wells Fargo in 2010, Bonnie was a managing director at Citi Investment Research, where she covered the beverage and tobacco sectors in equity research. During her 15 years of experience as a sell-side equity research analyst, Bonnie has been a top-ranked Institutional Investor analyst. For 10 years, Bonnie was recognized by Institutional Investor magazine for the “All-America Research Team,” primarily ranking as No. 2 in the tobacco sector. Prior to joining Citi in 2002, Bonnie was the senior beverage and tobacco analyst at Credit Suisse since 1997. Bonnie is best known for her in-depth proprietary research and successful contrarian stock calls. She has been a guest speaker at numerous tobacco and beverage industry conferences. Bonnie earned an MBA in finance from the Sloan School of Management at the Massachusetts Institute of Technology and a B.A. in finance from the University of St. Thomas in St. Paul, Minnesota, USA.

Delon Human is a published author, international lecturer and health care consultant specializing in tobacco harm reduction, global health strategy, corporate and product transformation, and health communication. Persuaded by the value of tobacco harm reduction, Human has become a vocal advocate for a change in public health thinking, from the abstinence-only approach to a more pragmatic and expanded use of nicotine-delivery systems as a substitute or cessation tool for smoking. He authored the book Wise nicotine.

Graham Kayes is Alliance One International’s executive vice president for business relationship management and leaf. He assumed this position in July 2014. Mr. Kayes brings more than 25 years of experience in the tobacco industry to his current position. He joined Standard Commercial Corp., one of Alliance One’s predecessor companies, in 1988 and worked in a variety of roles throughout the African region. Most recently, Mr. Kayes served as regional director of the African region and managing director of the company’s Tanzanian subsidiary. Born in Malawi, but of British and Kenyan nationality, Mr. Kayes attended school in England and moved to Kenya when he joined the company. He is currently located in the Alliance One headquarters in Morrisville, North Carolina, USA.

Patricia Kovacevic is general counsel and chief compliance officer for Nicopure Labs LLC, a leading U.S. e-liquid and vaping device manufacturer. Previously, Patricia was director of regulatory affairs and associate general counsel for Lorillard Tobacco Co. Kovacevic also directed the domestic and international regulatory and compliance strategy for recently acquired e-cigarette affiliate Blu. Under her direction, Lorillard secured the first-ever substantial equivalence orders for conventional cigarettes. Prior to joining Lorillard, Kovacevic was a partner at Patton Boggs and a senior counsel at Philip Morris International. In the past, she was a United Nations staff member, served on the U.N.’s Public-Private Partnership Commission and was also an adviser to the Council for Burley Tobacco.

Chris Kozlik has 28 years of experience working in the print and packaging industry, the last 14 of them associated with the tobacco sector, working for Lawson Mardon, Alcan and Parkside Flexibles. As development director for Parkside Flexibles, Kozlik combines the entrepreneurial culture of the business with his technical and creative skill sets to develop new and innovative ways to pack tobacco products.

Michael Lavery is director and senior analyst covering the tobacco space at CLSA. He was named the No. 1 stock picker in tobacco in 2013 by StarMine. He also supported coverage of beverages and household products at CLSA. Prior to CLSA, he worked at Kraft Foods and covered food manufacturers at Citigroup for four years before spending two years working with consumer companies in a consulting role at Booz & Company. Michael holds an MBA from Columbia Business School and a Bachelor of Science degree in commerce from the University of Virginia. Prior to business school, Michael was in public accounting at PricewaterhouseCoopers in Richmond, Virginia, USA, and in a financial analyst role at Swedish Match.

Duane Layton is head of Mayer Brown’s Government and Global Trade Group in Washington, Europe, Asia and Latin America. His practice concentrates on international dispute settlement, including World Trade Organization (WTO) disputes, international trade and investment law, and international trade negotiations and policy. Duane has extensive experience representing governments and industries in import relief proceedings (i.e., anti-dumping, countervailing duty and safeguard), both in the United States and abroad. Layton has litigated numerous disputes before the WTO in Geneva, including the first two anti-dumping cases to come before the WTO. Layton has also litigated numerous international trade disputes before the U.S. Court of International Trade, the U.S. Court of Appeals for the Federal Circuit and binational panels convened under Chapter 19 of the North American Free Trade Agreement. Layton was recently appointed to the international trade update advisory board of the Georgetown University Law Center.

Brian W. Lee for the last six years has been responsible for implementing track and trace within Japan Tobacco International (JTI) in more than 17 factories, 210-plus production lines and more than 50 markets. During this time he has represented JTI on the Digital Coding & Tracking Association (on the technical committee) and has been its chair for the past three years. Prior to his current position, for 10 years Lee was the head of capital expenditure procurement for the Japan Tobacco group. After completing an engineering tool apprenticeship at a hard-metal producer, Lee went on to study at the U.K.’s Institute of Industrial Management (IIM). He has held numerous positions within the factory environment, including production supervisor, stock controller and commercial manager, before becoming group IT manager, where he has been responsible for implementing a number of ERP solutions and the development of various software applications, including manufacturing, global integrated procurement and global product specifications.

Kgosi Letlape is the current president of the Africa Medical Association and the immediate past chairman of the board of the South African Medical Association. He is also past president of the World Medical Association (WMA), the global representative body for physicians worldwide. He is also the executive director of the Tshepang Trust, a foundation dedicated to improving the management of HIV/AIDS in South Africa. Letlape made history by becoming the first black person to qualify as an ophthalmologist (University of Edinburgh) in South Africa during apartheid, and he was the first black person to be elected as WMA president.

Mike Ligon is vice president of corporate affairs at Universal Corp., responsible for worldwide management of government and corporate affairs. He focuses on regulatory issues related to the U.S. Food and Drug Administration’s Family Smoking Prevention and Tobacco Control Act and the World Health Organization’s Framework Convention on Tobacco Control, as well as trade agreements under the World Trade Organization. Ligon joined Universal in 1982. His previous positions include president of Universal’s Casa Export, president of America’s Harvest and sales director for Universal Leaf North America. Ligon serves on the tobacco industry-related boards of Eliminate Child Labor in Tobacco and TMA.

Mark Littlewood is the director general of the Institute of Economic Affairs and the IEA’s Ralph Harris Fellow. Under his leadership, the IEA has continued to communicate the benefits of free markets to an even wider audience around the world. In 2014, Mark was ranked 38th on The Times’ right-wing power list and in 2011 was named Liberal Voice of the Year by the Liberal Democrat Voice. Mark frequently comments on political and economic issues on television and radio, including BBC Question Time, Any Questions?, Newsnight, Channel 4 News, Sky News, Radio 4’s Today and LBC. Prior to the IEA, Mark was head of media for the Liberal Democrats before going on to found Progressive Vision, a classical liberal think tank. He was also campaigns director for the human rights group Liberty and founder of NO2ID, the campaign against the introduction of identity cards. Mark was educated at Balliol College in Oxford, U.K.

Rolf Lutz is director of product policy at Philip Morris International (PMI), based in Lausanne, Switzerland. For more than 15 years, he has been leading and supporting PMI’s global public policy work regarding tobacco product regulation. Lutz advises PMI’s global functions, regions and markets in defining PMI’s approach to current and future regulatory requirements for conventional tobacco products, especially with regard to additives, contents, emissions and product design. He frequently participates in policy dialogues with regulators and other key stakeholders and is active in several international industry working groups. Lutz joined PMI in 1991 as a chemist and since then has held a wide range of positions in PMI’s global functions, such as R&D, operations and regulatory affairs, as well as in quality assurance and business development in the Philippines.

Andrew Manson is head of scientific engagement at British American Tobacco, responsible for leading regulatory engagement on both tobacco and nicotine products. He has worked for BAT for 24 years in the following senior management positions: head of group strategic research, group quality manager, group product development manager and regional product manager for Asia Pacific and European regions.

Marco Mariotti was appointed senior vice president of corporate affairs for Philip Morris International (PMI) in July 2015. In this role, he leads PMI’s regulatory, fiscal, contributions and communications strategies globally and oversees the company’s efforts to combat illicit tobacco trade. Since joining PMI in 1997, Mariotti has held numerous leadership roles in Argentina and across Europe. He started in business development for the EU region and moved to Italy in 2001 as director of finance and then director of corporate affairs. In 2005, Mariotti was appointed managing director for Argentina, followed by his appointment as managing director for Italy in 2008. Most recently, Mariotti served as president for Russia and Belarus, a position he held from September 2010. Before joining PMI, Mariotti worked in the financial sector in Switzerland. He studied economics in Lausanne, Switzerland, and holds an MBA from INSEAD in Fontainebleau, France.

Ambassador Stephen D. Matenje was until April 30th, 2015 Ambassador Extraordinary and Plenipotentiary of the Republic of Malawi to the United States of America since September 16th, 2010. He was also accredited to the Bahamas, Canada, Cuba, the Dominican Republic, Mexico and Puerto Rico on a non-residential basis. During his tenure as Malawi’s Ambassador to the United States, he was in the forefront in, among other things, promoting a preferential trade program enacted by the United States Congress to stimulate economic development in eligible African countries, including Malawi. Prior to his appointment as Malawi’s Ambassador to the United States. Ambassador Matenje served as Malawi’s Ambassador to the United Nations from November 2006 to May 2010 and as Solicitor-General of Malawi and Permanent Secretary in Malawi’s Ministry of Justice from September 1995 to July 2006. He previously served as Parliamentary Counsel. As Solicitor-General, he was involved in advising the Malawi Government on a wide range of legal issues and represented the Malawi Government in constitutional and judicial review cases. Ambassador Matenje joined the Malawi Public Service in 1980 as a State Attorney.

Neil McKeganey is the director of the Centre for Drug Misuse Research in the U.K. He has undertaken empirical and policy studies of drug use across diverse areas, such as preteen drug use, drugs and prostitution, the impact of parental drug use on children, evaluations of the effectiveness of drug treatment services, the impact of drugs enforcement and the determinants of drugs policy. He is the author of over 180 peer-reviewed papers and has authored or co-authored eight books. His most recent book, published by Macmillan, is The A to Z of Substance Misuse (2013). He is currently writing a book on drugs policy reform for Macmillan.

Lorenzo Montanari is executive director of Property Rights Alliance (PRA), an advocacy group/think tank based in Washington, D.C., USA, committed to the protection of physical, legal and intellectual property rights around the world. On the international stage, PRA works closely with famed property rights champion and President of the Institute for Liberty and Democracy (ILD) in Lima, Peru, Hernando de Soto and 81 other think tanks. At Property Rights Alliance, he is in charge of publishing the International Property Rights Index, an international comparative study focused on intellectual and physical property rights. Previously, he worked for a public affairs firm at the international department of the Graduate School of Political Management at George Washington University in Washington, D.C., and as a political analyst and electoral observer in Latin America. Montanari holds a B.A. in political science and in international relations from the University of Bologna and an M.A. in political management from George Washington University. He collaborates with The Daily Caller and Forbes.

Marina Murphy is scientific reputation manager at British American Tobacco. Marina joined BAT in 2008 and has held roles including international scientific affairs manager and scientific communications manager. She has been a driving force behind a communications and outreach strategy designed to reflect BAT’s transparent approach to scientific communication. The strategy is designed to provide clear communication and engender debate on the company’s ambitious tobacco harm-reduction research program, including the creation of lower-risk tobacco products. Prior to joining BAT, she was a science journalist.

Masibonge Mzwakali is manager of corporate affairs for sub-Saharan Africa for Philip Morris International (PMI), a position he has held since 2013. Prior to working for PMI, Mzwakali worked for South Africa’s Department of Transport from 2012 to 2013 as head of parliamentary services and stakeholder engagement in the Office of the Minister. From 2011 to 2012, he worked at the Department of Public Enterprises as media liaison officer in the Office of the Deputy Minister. Mzwakali was educated at the University of Cape Town, where he earned a Bachelor of Arts in political studies and law. In 2008, he was admitted as an attorney of the High Court of South Africa, and in 2012 he received a postgraduate diploma in corporate law from the University of Johannesburg.

Ray Niaura is director of science and training at the Schroeder Institute for Tobacco Research and Policy Studies at Legacy; adjunct professor in the Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health; and adjunct professor in the Department of Oncology at the Lombardi Comprehensive Cancer Center at the Georgetown University Medical Center. He has been principal investigator or co-investigator of over 30 NIH-funded grants, and he is the former president of the Society for Research on Nicotine and Tobacco. He was the principal investigator of the NCI-funded Transdisciplinary Tobacco Use Research Centers on Nicotine Dependence: Phenotype, Endophenotype and Contexts at Brown University. He is a co-investigator on the Population Assessment of Tobacco and Health (PATH) study sponsored by the National Institute on Drug Abuse and the U.S. Food and Drug Administration Center for Tobacco Products. PATH is a national, longitudinal cohort study of 60,000 users and nonusers of tobacco products ages 12 and up.

Paul Neumann was appointed senior vice president of global leaf for Japan Tobacco International in October 2009. He started his career with RJR-MacDonald Inc. in Toronto as director of finance in 1987 and was later promoted to regional vice president of finance and chief financial officer for the Americas. In 1994 he relocated to Geneva in the same role for the CIS and Baltics. Appointed vice president, CFO, of global supply chain in 1999, he subsequently held the role of vice president of finance for the European region in 2006. Before his current assignment, he was appointed vice president of global leaf procurement in 2007. Neumann is a Canadian national and holds an Honors Bachelor of Commerce degree from Carleton University. He is a chartered accountant and certified management accountant in the Ontario Institutes.

Daniel Nuesslein is working as manager for IT solutions in the tobacco industry at HERMOS AG, an international operating company group in the area of automation and data processing. His 10 years of experience involve a wide range of IT solutions in tobacco primaries and secondaries all around the world, particularly manufacturing execution systems and track-and-trace solutions.

Mike Ogden is RAI Services’ senior director for regulatory oversight, based in North Carolina, USA. Ogden is responsible for scientific and regulatory advocacy and engagement for all Reynolds American tobacco operating companies. Previously, Ogden was in charge of various R&D programs for R.J. Reynolds Tobacco Co., including those related to environmental tobacco smoke, measuring smoke uptake in smokers through the use of biomarkers, smoking behavior research, clinical studies, regulatory compliance activities, and scientific and regulatory strategy.

Flora Okereke is currently head of regulatory policy and engagement at British American Tobacco headquarters in the U.K., where she has held various roles, including head of legal services for West Africa and head of regulation for the Eastern European, Middle East and Africa region. Prior to joining BAT, Okereke was a solicitor in a City of London law firm and was admitted as a barrister of the Honourable Society of the Middle Temple. Okereke is also a barrister and solicitor of the Supreme Court of Nigeria. Flora has been involved in opposing plain packaging in the past four years.

Tim Oliver has a production management and purchasing background and has worked in the agricultural supply sector since 1979. He has held various senior management roles in the industry and is currently program development director with AB Sustain, which works with commercial enterprises to design, develop and deliver programs that address sustainability issues in agricultural supply chains. Since the 1990s, Oliver has worked closely with the U.K. feed industry in the development of its assurance programs, with a particular focus on ensuring the safety of feed ingredients sourced from around the world. Since 2006, Tim has been involved in developing programs focused on sustainability, working particularly with the soy, tobacco and sugar industries. Tim is a certified lead assessor, with experience in the application of risk assessment techniques, and has undertaken supply chain work across Europe and the Americas and in Africa and Asia.

David O’Reilly is British American Tobacco’s (BAT) group scientific and R&D director. He graduated from Imperial College London in 1991 with a Ph.D. in molecular virology. He continued to pursue this area of research when he joined Advanced Technologies Cambridge, a BAT subsidiary, where he studied the potential of genetic modification to introduce novel processing and agronomic traits into tobacco and other crops. O’Reilly has been a driving force behind BAT’s multidisciplinary global R&D effort in consumer-led, science-based innovation in both combustible and next-generation tobacco and nicotine products. He has also led the company’s programs in corporate social responsibility and scientific and public health policy and engagement. O’Reilly is the current chairman of the Global Tobacco & Nicotine Forum advisory board.

Antonella Pederiva is secretary-general of the Confederation of European Community Cigarette Manufacturers (CECCM), starting in 2003. She joined the CECCM in 1999 as director for institutional affairs after working in the Brussels offices of the Italian farmer union Coldiretti and the Italian dairy industry association Assolatte. She represents the CECCM externally, has the general responsibility of the secretariat and supervises all its activities. She also provides support and strategic advice to the CECCM board and executive committee. She has been actively involved in the revision process of the EU Tobacco Product Directive (TPD) by representing the common views of the member companies externally and coordinating internal discussions.

Roger Penn is director of the Switzerland-based Mane Group tobacco business unit, which has laboratories in Brazil, China, France, Mexico, Switzerland and the United States. Before joining Mane, he worked for British American Tobacco in the U.K. and in the flavor industry for companies such as Unilever, Firmenich and IFF. With advanced degrees in medicinal chemistry and toxicology, Penn has contributed to many international scientific and technological conferences in the tobacco and flavor industries. Penn travels extensively to assist customers with product development.

Carl Phillips is a consultant and freelance researcher in epidemiology and economics, and he is the scientific director for The Consumer Advocates for Smoke-free Alternatives Association. He has worked in tobacco harm-reduction (THR) research, education and advocacy, and is one of the few who have been in the field for more than a decade, starting during his previous career as a professor of public health. His current work focuses on chronicling and analyzing the experiences of consumers who have employed THR and on population modeling of product adoption.

Riccardo Polosa is a professor of internal medicine and head of the Institute of Internal and Emergency Medicine at the University of Catania, Sicily, Italy, where he founded and supervises the Center for Tobacco Research. He is also scientific advisor for the LIAF (Italian Anti-Smoking League) and coordinator of the Italian working group at the European Committee for Standardization for e-cigarettes and liquid matter. His main research interests are tobacco-related diseases, smoking prevention and cessation, tobacco harm reduction and risk assessment of new nicotine-containing products. He is the principal investigator of the first RCT in the world on the safety and effectiveness of electronic cigarettes in smokers unwilling to quit (ECLAT study, 2013). According to recent bibliometric research, he is the most productive author in the international scientific scene thanks to his research in the fields of electronic cigarettes and tobacco harm reduction.

Guillaume Popiol is the director of corporate affairs for sub-Saharan Africa for Philip Morris South Africa in Cape Town, South Africa. From 2013–2014 he was director of leaf for Africa at Philip Morris South Africa in Cape Town, and from 2010–2012 he served as manager of leaf planning for Africa at Philip Morris South Africa in Cape Town. From 2009–2010, Popiol was manager of leaf projects at Philip Morris International in Lausanne, Switzerland. From 2008–2009 he was manager of leaf planning at Philip Morris International in Lausanne. From 2004–2007 he was manager of leaf controls at Philip Morris International in Lausanne, and from 2000–2004 he was corporate lead auditor at Philip Morris International in Lausanne. From 1997–2000, he served as finance manager of Elf Oil Switzerland SA in Geneva, Switzerland. Popiol earned an M.S. in management at EUROMED, Marseille, France, in 1996.

Christopher Proctor is British American Tobacco’s chief scientific officer. He oversees research programs that ensure product stewardship of conventional and next-generation tobacco and nicotine products, as well as the development of methodologies to determine whether next-generation products can be described as reduced-risk products. He is an author of numerous scientific papers related to tobacco harm reduction and has published a book that looked at the importance of the interaction between science, policy and consumers.

Antonio Ramazzotti is the vice president of market research and innovation at Philip Morris International (PMI). Ramazzotti is responsible for driving the deep and actionable adult smokers’ understanding for both PMI’s reduced-risk products and their combustible brand portfolio. He is also responsible for the coordination of the company’s portfolio of product innovation. He joined PMI in 2004 and has held a variety of roles in PMI’s marketing and sales functions, focused on the application of adult smokers’ understanding to build PMI brands. Ramazzotti has 27 years of experience in the FMCG industry, with Procter & Gamble from 1988 until 2004 and with PMI since then.

Michiel Reerink is global regulatory strategy vice president at Japan Tobacco International (JTI). He started his career in the tobacco industry in 1996 at a tobacco trade association in the Netherlands. In 2001, he joined a major tobacco company to take responsibility for corporate affairs in the Netherlands, Benelux (Belgium, the Netherlands and Luxembourg) and Germany. In 2004, he established the company’s EU affairs office in Brussels and subsequently led its EU engagement. In 2010, Reerink joined JTI at the Geneva headquarters to head the global regulatory strategy department, which leads JTI’s strategy and responses to emerging global priority issues, including plain packaging.

Jed E. Rose, is director of the Duke Center for Smoking Cessation and professor in the department of psychiatry and behavioral sciences at Duke University Medical Center. Rose is a leading authority on the treatment of tobacco addiction. In the early 1980s, Rose led the initial studies of transdermal nicotine administration, which helped pave the way for the development of commercial nicotine skin patches as a smoking cessation treatment. He also conducted pioneering studies into the role of sensorimotor aspects of cigarette smoking. Since then, Rose and his colleagues have continued to develop smoking cessation treatments, including novel nicotine-replacement strategies, nicotinic antagonists and extinction-based treatments to enable smokers to quit smoking more successfully. Their studies of agonist-antagonist treatment provided support for the development of varenicline as a partial agonist for smoking cessation treatment. In addition to developing more effective treatments, Rose’s research program strives toward a deeper understanding of tobacco dependence. His research is currently applying brain-imaging methodologies, including positron emission tomography (PET) and functional magnetic resonance imaging (fMRI), to identify brain substrates underlying craving and addiction. Genomic predictors of quit-smoking success are also being identified, as well as gene variants associated with menthol preference. The knowledge gained from this basic research program will be applied to the design of novel therapeutic approaches and to the development of algorithms for personalizing treatment so that each individual smoker receives the treatment most likely to yield a successful outcome.

Christopher Russell is a research fellow at the Centre for Drug Misuse Research in the U.K. He is conducting research on the design, delivery and evaluation of health behavior change interventions. His research expertise is the measurement and modeling of the psychosocial, affective, policy and product factors associated with changes in smoking behavior and consumer perceptions of product attractiveness, performance, labeling and marketing. Russell’s research aims to inform more effective harm-reduction treatment of nicotine dependence and improve public health education around the use of tobacco- and nicotine-containing products.

Dr. Carlo Sacchetto is secretary-general of the European (FETRATAB) and the Italian (APTI) tobacco processors associations and secretary of the Italian raw tobacco interbranch organization (I.O. Tabacco Italia). Sacchetto has a Master of Science with honors in agricultural sciences from the University of Perugia and an MBA of the agriculture and food sector from the Catholic University in Milan. He has more than 35 years of experience in agribusiness, having worked eight years with the biggest European agricultural cooperative network, five years in real estate and big farms direct management, eight years with the Italian ministry of agriculture (head of the international relations office and head of the technical secretariat of the minister) and state-owned agribusiness financial company, and, up to date, 15 years in the tobacco business. He has wide competence in the European and world raw tobacco markets, laws and regulations experienced at the world level (WTO TBT, WHO FCTC). He has experience with national government, European and world institutions (EU, FAO, ILO, IUF) and tobacco stakeholders organizations (CECCM, UNITAB, ITGA, EFFAT, etc.), having been several times a member of governmental delegations at international meetings. He is a member of the board of directors or auditors of a number of firms operating in food and agribusiness, real estate, and the book industry. His specializations include European- and world-level tobacco regulation, institutions relations, corporate social responsibility, sustainability, market analysis, trade unions negotiations and congress organization.

Ernesto Savona is the director of TRANSCRIME, Joint Research Centre of the Università Cattolica del Sacro Cuore and the Università degli Studi di Trento and, since 2003, professor of criminology at the Università Cattolica del Sacro Cuore in Milan. In 2003 he was appointed editor-in-chief of the European Journal on Criminal Policy and Research. He is also editor-in-chief of the series Research in Brief in International and Comparative Criminology. He has been consultant to the United Nations, Council of Europe, the European Union (EU) and various national governments. Today, he is a member of the EU Commission experts group, “Policy Needs for Data on Crime and Criminal Justice” and of the expert group on firearms. He has published extensively on organized/economic crime, corruption, money laundering, mafias and prevention policies against organized crime and illicit markets. His last research interests are in finding indicators for the measurement of organized crime and its illicit activities in Europe, and for the measurement of illicit markets.

Uwe Schey is a chief operating officer of Xavo AG, an information technology company in the manufacturing IT area. He was involved in a variety of industry IT solutions, including manufacturing execution systems, track-and-trace and product authentication solutions. Prior to joining Xavo, Schey worked for British American Tobacco.

Upon receiving a Bachelor of Science degree in agronomy and minor in agricultural business management from North Carolina State University in 1994, Lea Scott joined Universal Leaf as an international agronomist. For nearly 20 years Lea has worked with Universal’s worldwide agronomists and field technicians to improve sustainable tobacco production in Africa, Asia, Europe, and the Americas. Currently the vice president of agronomy services, Lea coordinates Universal’s global agronomy and agronomic R&D programs and represents Universal on agro-science industry matters. Lea has been an active member of Coresta, serving several terms on the Scientific Commission, including terms as the secretary and president, respectively, of the Agronomy Study Group, and was the coordinator of the Task Force on Good Agricultural Practices. Currently Lea is the vice-chairman of the Agro-Chemical Advisory Committee (ACAC) and member of Coresta’s sustainability task force.

Dr. Will Snell was raised on a beef and tobacco farm in Central Kentucky. He received his B.S., M.S. and Ph.D. from the University of Kentucky. Snell joined the Department of Agricultural Economics at the University of Kentucky in May 1989 with a split Extension/teaching appointment. His Extension program has focused on tobacco economics, agricultural policy, trade, and the macro agricultural economy. During his career at the university, he has made more than 1,000 presentations to local, regional, state, national and international audiences, including testimonies before various committees of the U.S. Senate, U.S. House of Representatives and the Kentucky General Assembly. Snell currently serves as the co-director of the Kentucky Agricultural Leadership Program and teaches an undergraduate class in food and agricultural marketing.

Chris Snowdon is an independent author and historian whose works include Velvet Glove, Iron Fist: A History of Anti-Smoking (2009). He has a degree in history from Lancaster University, in the U.K., and has written about a wide range of issues relating to liberty and public health for Spiked, Environment & Climate News, Pipes and Tobaccos, and The Free Society. His most recent book is The Spirit Level Delusion (2010).

Valerie Briggs Solomon is currently a senior director within the Regulatory Oversight department of RAI Services Company. Among other responsibilities, Valerie oversees regulatory compliance and assurance for Reynolds American Inc.’s operating companies. Prior to joining RAI Services in 2010, Valerie was an attorney in Washington, D.C., where she counseled clients in the food, medical device and pharmaceutical industries on various regulatory, litigation and policy matters.

Jim Solyst is the vice president of federal regulatory affairs with Swedish Match North America, where he coordinates the company’s modified risk tobacco product (MRTP) process and related regulatory science engagements. He has held senior positions in Washington, D.C.-based companies and associations, including the National Governors Association, American Chemistry Council and the consulting firm ENVIRON International Corp. During his 30-plus years in Washington, he has worked closely with federal agencies, including the Environmental Protection Agency, the U.S. Food and Drug Administration and the Office of Management and Budget. He has also worked with international organizations, including the United Nations, World Health Organization and Organization for Economic Cooperation and Development. Solyst is a member of the Food Drug Law Institute (FDLI) Tobacco Committee, as well as the American Chemical Society Committee on Environmental Improvement. He is also a member of the National Academy of Sciences (NAS) Chemical Sciences Roundtable and served on the NAS Committee on Promoting Safe and Secure Chemical Management in Developing Countries. He also serves as an external affiliate to the Johns Hopkins Risk Sciences and Public Policy Institute. Solyst has written several articles and given numerous presentations on a range of regulatory science and public policy issues.

Elizabeth A. Stevulak, is the director of educational programs at the Food and Drug Law Institute (FDLI) in Washington, D.C. In this capacity she leads the curriculum development team for all of the FDLI’s conferences, webinars and introductory courses in all areas of food and drug law—including foods, dietary supplements and devices—in addition to managing the FDLI’s drugs and tobacco portfolios. In addition to planning and overseeing the content for the FDLI’s largest meetings, including the FDLI’s Annual Conference and the FDA regulation of tobacco products conference, Stevulak manages the FDLI’s tobacco, global, and drugs advisory committees. She currently serves as the editor-in-chief of the Food and Drug Law Journal and frequently contributes pieces to the FDLI’s Update magazine. Stevulak earned a J.D. from the University of the District of Columbia David A. Clarke School of Law and a B.A. in political science from the University of Arizona. Before attending law school, Stevulak worked as a government relations professional for the Society of Chemical Manufacturers and Affiliates and the Business Industry Political Action Committee.

Jeff Stier is a senior fellow at the National Center for Public Policy Research in Washington, D.C., and heads its risk analysis division. Stier frequently addresses domestic policy issues in the media, including on CNN, Fox News, Al-Jazeera America and CNBC, among others. He’s a guest on more than 100 radio shows a year, including NPR and other nationally syndicated radio shows, as well as top-rated major market shows. Mr. Stier’s National Center op-eds have been published in top outlets including The Wall Street Journal, USA Today, Los Angeles Times, New York Post, Forbes, The Washington Examiner and National Review Online. His more scholarly writing has been published in the Hoover Institution’s journal, Defining Ideas, and the Cato Institute’s Regulation and Springer’s Cancer Causes & Control.

Steve Stotesbury is head of regulatory science for the Imperial Tobacco Group. He has been a tobacco scientist for more than 20 years and is passionate about bringing balance to the tobacco regulatory debate and promoting the use of scientific evidence and reasoning in public discussion. After obtaining his Ph.D. in chemistry in 1984, he worked as a scientist for the U.K. Ministry of Defence before joining British American Tobacco in the early 1990s. Since 2000, he has represented Imperial Tobacco externally on many scientific and regulatory matters, including appearing before Health Select Committees in the U.K. As head of regulatory science, he is a specialist for product regulation, covering both the current tobacco-product portfolio as well as new product categories, including e-cigarettes.

Juergen Tiemann, director of leaf purchasing and manufacturing innovation for Imperial Tobacco, is based in Hamburg, Germany. In this role, he is responsible for procuring the global leaf requirements and for providing innovative product solutions. Tiemann joined the tobacco industry in 1979 as a leaf trainee with BAT. He spent five years buying and processing tobacco in Asia and Africa, working for leaf supplier Gebrueder Kulenkampff, now part of Universal Corporation. He joined the Reemtsma leaf department in 1987 and became part of Imperial with the acquisition in 2002. During the last 28 years, Tiemann held various roles within leaf purchasing and became head of the department in 2007. In 2008 leaf blending was added to his responsibilities. Tiemann was appointed director of leaf purchasing and product development in 2010 and took over his current position in 2012.

Marina Trani is head of research and development for Nicoventures, a role she took up following a brief onboarding role as BAT¹s group head of scientific product stewardship. Previously, for 25 years, Trani was in R&D at Procter & Gamble, where she rose to become global beauty care R&D director, having worked across a variety of products categories including home care, beauty and health care. Trani has a proven track record in managing all aspects of the innovation process, from the identification of new opportunities to developing new products, including resourcing and all the way to the in-market execution.

Brigadier General Richard J. Tubb, MD, White House physician, emeritus, was the physician to the 43rd president of the United States. He was responsible for providing direct support and advice to the president and oversaw all healthcare services delivered to the president, the vice president, the Cabinet and their senior advisers. In January 2013, Tubb was appointed as the first clinical/science-based nonexecutive director on the board of British American Tobacco (BAT), where he will help lead BAT’s entry into next-generation products and tobacco harm reduction. He has partnered with former senior political leaders in Canada and the U.S. to advise startup companies battling infectious disease and smoking-related diseases.

Ron Tully is founder of TNV Ventures, a specialty consultancy in the tobacco, nicotine and vapor space. Tully is also a partner in Next Generation Labs, a company established in 2014 to develop nontobacco nicotine sources for the tobacco, vapor and pharmaceutical industries. Most recently Tully worked closely with other industry leaders to set up a new U.S. industry trade group to represent the vapor industry, called the Vapor Technology Association (VTA). Tully is also a recent founder of Calumet Advisors, a New York-based consultancy support service for the vapor industry with a specific focus on U.S. regulatory and market entry strategies for new companies in the vapor space. Ron has a long history in tobacco, having joined the industry in 1988. He has worked in public policy at the federal, state and international levels, and he has also been closely involved in new business development and new product roles for a number of companies, most recently with his past employer, National Tobacco Company, where he was previously vice president of public affairs and new project initiatives.

Francois Van Der Merwe has been involved in the tobacco industry for more than 30 years. As a tobacco farmer he has a close understanding of farmers’ challenges but also of the many issues faced by the manufacturing sector. He is currently the chairman and CEO of The Tobacco Institute of Southern Africa, which deals with matters pertaining to farmers, processors, merchants, manufacturers, exporters and importers of tobacco products. Since 1998, he has represented South Africa at the International Tobacco Growers’ Association (ITGA). He is currently the global president of the ITGA, as well as chairman of the ITGA Africa region.

Pieter van Rennes is technical sales manager at Oxy-Low Systems, a company specializing in the quality preservation and post-harvest pest control of tobacco products. Pieter started his career as a technical engineer in post-harvest pest control in 2003, and he joined Oxy-Low Systems in 2014. With more than 10 years of experience in the design and installation of controlled-atmosphere treatments, he has gained extensive knowledge in the usage of controlled atmosphere as a quality-preservation and alternative pest-control method.

Huub Vizee has spent the last 28 years working within the tobacco industry in many different areas, including leaf, research, engineering, quality, product development and corporate affairs. Since September 2011, he has worked for Delfortgroup, based in Wattens, Austria, as head of regulatory affairs. In this role he is responsible for dealing with all tobacco-related regulatory issues worldwide and also represents Delfortgroup on the board of Coresta as vice president. In his previous positions, he worked for Van Nelle, Douwe Egberts and Imperial Tobacco, where his last position was head of group regulatory development. In this role he was responsible for leading Imperial Tobacco’s regulatory engagement as an active participant on global, regional and market levels. In this role he also represented Imperial Tobacco on the board of CECCM, the board of ECMA and the board of Coresta.

Nico Vroom is the managing director and head of the research and development department at EcO2 BV. Vroom is an expert in the development, research and implementation of various kinds of treatments (nonchemical with controlled atmosphere and chemical with phosphine) in post-harvest pest control. He has an extensive knowledge of integrated pest management, entomology and construction advisements to give those species found in post-harvest products and storage facilities no chance. He has for two years been involved with European research programs for resistant insects, and has been an active member of the Coresta infestation pest management group since 2008. In the past decade, Vroom has specialized in pest control during the post-harvest storage of tobacco and has become familiar with the current issues of resistance and residues of all kinds of species worldwide.

Wan Saiful Wan Jan is CEO of the Institute for Democracy and Economic Affairs, which was ranked as Asia’s best new think tank and the world’s fifth-best new think tank by the University of Pennsylvania in 2012. He is a member of the advisory board at Laureate International Malaysia; a member of the advisory board of the England’s University of Nottingham’s School of Politics, History and International Relations; and a governor at Rafflesia Education Group. From 1993 to 2009, Wan served several U.K. organizations, including the Commonwealth Policy Studies Unit, the British Conservative Party’s Research Department and Social Enterprise London.

Kingsley Wheaton was appointed managing director of British American Tobacco’s (BAT) next-generation products (NGP) in January 2015. Nicoventures is part of NGP. He joined BAT in 1996 and has held a number of roles in marketing. He was marketing director in Nigeria and Russia before becoming general manager in Russia—one of the group’s most significant businesses. He was then the global brand director responsible for Kent and Vogue before taking his place on the management board in January 2012 as deputy corporate and regulatory affairs director. In June 2012 he was appointed director of corporate and regulatory affairs.

Rupert Wilson is the owner and managing director of Strategic Business Consulting in the U.K. Prior to founding the company in 2000, he worked at Rothmans International for 17 years in a variety of senior management positions in Africa, Central and Eastern Europe, and at Rothmans’ global head office, specializing in business development, project management and strategic planning. Wilson is now a retained consultant to many major financial institutions in Asia, the U.K. and the U.S., advising on their global tobacco investments. He has also been for many years one of the top-ranked tobacco and luxury goods analysts in South Africa, according to the annual Financial Mail analyst rankings.

Julie Woessner is the executive director of the Consumer Advocates for Smoke-free Alternatives Association (CASAA). CASAA, a nonprofit U.S.-based public health and education NGO, is the world’s leading advocate for people who consume, or might in the future consume, low-risk alternatives to cigarettes. CASAA engages in policy advocacy in the U.S. involving legislative and regulatory matters to protect access to low-risk products and mobilizes its 70,000-plus members to do the same. Internationally, CASAA provides education about tobacco harm reduction and advocacy. Woessner holds a J.D. from the Duke University School of Law and was previously a practicing attorney.

Yushu Zhu worked in the pharmaceutical industry for 21 years, with 15 years in China and six years in the U.K. He has worked with international pharmaceutical and biotechnology companies on custom strategy for drug development and manufacturing. He was a regular speaker in many international pharmaceutical conferences, and he was also a columnist for a leading Chinese pharmaceutical journal. Yushu is a member of the Chartered Institute of Marketing in the U.K. and has been a Chartered Marketer since 2004.








Hosted By: